References

1. Fukuoka J, Tominaga M, Ichikado K, Tanaka T, Ichiyasu H, Kohrogi H et al. Lung miliary micro-nodules in human T-cell leukemia virus type I carriers. Pathol Int. 2013; 63(2): 108-12. PubMed | Google Scholar


2. Boury GS, Fatou F, Bécaye F, Khadidiatou BF, Papa Diadié F, Bineta N et al. La leucémie-lymphome à cellules T de l'adulte due au HTLV-1: à propos de huit cas au Sénégal. Hematologie. 2012; 18(1): 67-71. PubMed | Google Scholar


3. Primo J, Siqueira I, Nascimento MCF, Oliveira MF, Farre L, Carvalho EM, Bittencourt AL. High HTLV-1 proviral load, a marker for HTLV-1-associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1. Braz J Med Biol Res. 2009; 42(8): 761-4. PubMed | Google Scholar


4. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012 Nov 15; 3: 388. PubMed | Google Scholar


5. Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T et al. Integration patterns of htlv-i provirus in relation to the clinical course of atl: frequent clonal change at crisis from indolent disease. Blood. 1997 Feb 1; 89(3): 948-56. PubMed | Google Scholar


6. Césaire R, Lézin A. Epidemiologie, pathogenèse et expression cliniques des infections à HTLV1. La lettre de l'infectiologue. 2003; 18: 5-10. Google Scholar


7. Gessain A. Le rétrovirus humain oncogène HTLV-1: épidémiologie descriptive et moléculaire, origine, évolution et aspects diagnostiques et maladies associées. Bull Soc Pathol Exot. 2011 Aug; 104(3): 167-80. PubMed | Google Scholar


8. Mahieux R. Aspects virologiques de l'infection par HTLV-1 et nouveaux concepts thérapeutiques. Bull Soc Pathol Exot. 2011 Aug; 104(3): 181-7. PubMed | Google Scholar